Activity of imipenem against Klebsiella pneumoniae Biofilms in vitro and in vivo

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1208-1213

  Chen, Ping ^a   Seth, Akhil K ^b   Abercrombie, Johnathan J ^a   Mustoe, Thomas A ^b   Leung, Kai P ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; NITROFURANTOIN; PIPERACILLIN; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; TOBRAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; CONTROLLED STUDY; EAR; EXPERIMENTAL RABBIT; IN VITRO STUDY; IN VIVO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SHEAR FLOW; WOUND HEALING;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; DERMIS; EAR; IMIPENEM; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; RABBITS; RE-EPITHELIALIZATION;

EID: 84893459115     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01353-13     Document Type: Article

References (22)

1. Podschun R, Ullmann U. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11:589-603.
2. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV. 2007. Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J. Clin. Microbiol. 45:3352-3359. http://dx.doi.org/10.1128/JCM. 01284-07.
3. Ressner RA, Murray CK, Griffith ME, Rasnake MS, Hospenthal DR, Wolf SE. 2008. Outcomes of bacteremia in burn patients involved in combat operations overseas. J. Am. Coll. Surg. 206:439-444. http://dx.doi.org/10.1016/j. jamcollsurg.2007.09.017.
4. Bennett JW, Robertson JL, Hospenthal DR, Wolf SE, Chung KK, Mende K, Murray CK. 2010. Impact of extended spectrum betalactamase producing Klebsiella pneumoniae infections in severely burned patients. J. Am. Coll. Surg. 211:391-399. http://dx.doi.org/10.1016/j.jamcollsurg.2010.03.030.
5. Lopez D, Vlamakis H, Kolter R. 2010. Biofilms. Cold Spring Harb. Perspect. Biol. 2(7):a000398. http://dx.doi.org/10.1101/cshperspect.a000398.
6. Leid JG. 2009. Bacterial biofilms resist key host defenses. Microbe 4:66-70.
7. Donlan RM. 2008. Biofilms on central venous catheters: is eradication possible? Curr. Top. Microbiol. Immunol. 322:133-161.
8. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, Madsen KG, Phipps R, Krogfelt K, Hoiby N, Givskov M. 2008. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen. 16:2-10. http://dx.doi.org/10.1111/j.1524-475X. 2007.00283.x.
9. Black CE, Costerton JW. 2010. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. Surg. Clin. North Am. 90:1147-1160. http://dx.doi.org/10.1016/j.suc.2010.08.009.
10. Lewis K. 2010. Persister cells. Annu. Rev. Microbiol. 64:357-372. http://dx.doi.org/10.1146/annurev.micro.112408.134306.
11. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A. 1999. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J. Clin. Microbiol. 37:1771-1776.
12. Brooun A, Liu S, Lewis K. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:640-646. http://dx.doi.org/10.1128/AAC.44.3.640-646.2000.
13. Spoering AL, Lewis K. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183:6746-6751. http://dx.doi.org/10.1128/JB.183.23.6746-6751.2001.
14. Kint CI, Verstraeten N, Fauvart M, Michiels J. 2012. New-found fundamentals of bacterial persistence. Trends Microbiol. 20:577-585. http://dx.doi.org/10.1016/j.tim.2012.08.009.
15. Araujo JC, Téran FC, Oliveira RA, Nour EAA, Montenegro MAP, Campos JR, Vazoller RF. 2003. Comparison of hexamethyldisilazane and critical point drying treatments forSEManalysis of anaerobic biofilms and granular sludge. J. Electron Microsc. 52:429-433. http://dx.doi.org/10.1093/jmicro/52.4.429.
16. Gurjala AN, Geringer MR, Seth AK, Hong SJ, Smeltzer MS, Galiano RD, Leung KP, Mustoe TA. 2011. Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen. 19:400-410. http://dx.doi.org/10.1111/j.1524-475X.2011.00690.x.
17. Seth AK, Geringer MR, Gurjala AN, Hong SJ, Galiano RD, Leung KP, Mustoe TA. 2012. Treatment of Pseudomonas aeruginosa biofilm-infected wounds with clinical wound care strategies: a quantitative study using an in vivo rabbit ear model. Plast. Reconstr. Surg. 129:262e-274e. http://dx.doi.org/10.1097/PRS. 0b013e31823aeb3b.
18. Fernandez-Torres R, Bello-Lopez MA, Callejon-Mochon M, Jimenez-Sanchez JC. 2008. Determination of imipenem and rifampicin in mouse plasma by high performance liquid chromatography-diode array detection. Anal. Chim. Acta 608:204-210. http://dx.doi.org/10.1016/j.aca.2007.12.026.
19. Rodloff AC, Goldstein EJ, Torres A. 2006. Two decades of imipenem therapy. J. Antimicrob. Chemother. 58:916-929. http://dx.doi.org/10.1093/jac/ dkl354.
20. Vidal R, Dominguez M, Urrutia H, Bello H, Garcia A, Gonzalez G, Zemelman R. 1997. Effect of imipenem and sulbactam on sessile cells of Acinetobacter baumannii growing in biofilm. Microbios 91:79-87.
21. Yamasaki O, Akiyama H, Toi Y, Arata J. 2001. A combination of roxithromycin and imipenem as an antimicrobial strategy against biofilms formed by Staphylococcus aureus. J. Antimicrob. Chemother. 48:573-577. http://dx.doi.org/10.1093/jac/48.4.573.
22. Furuhata M, Iwamura M, Baba S, Inoue M. 2003. Combined effect of clarithromycin and imipenem/cilastatin against urinary biofilm infection after pyeloplasty. Int. J. Urol. 10:228-230. http://dx.doi.org/10.1046/j.0919-8172. 2003.00598.x.